HCW Logo_Full_Color_600x_JPEG (2).jpg
HCW Biologics Reports Second Quarter 2023 Financial Results and Recent Business Highlights
August 11, 2023 07:00 ET | HCW Biologics, Inc
MIRAMAR, Fla., Aug. 11, 2023 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and...
HCW Logo_Full_Color_600x_JPEG (2).jpg
HCW Biologics is Granted Third Fundamental Patent: U.S. Patent for Methods of Treating Age-Related Disorders
June 14, 2023 07:30 ET | HCW Biologics, Inc
MIRAMAR, Fla., June 14, 2023 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (“HCW Biologics” or the “Company”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and...
HCW Logo_Full_Color_600x_JPEG (2).jpg
HCW Biologics Poster Presentation at AACR Annual Meeting 2023
April 13, 2023 07:15 ET | HCW Biologics, Inc
Presentation of data for the mechanism underlying HCW9218 against solid tumors HCW9218 is the clinical-stage, lead product candidate of HCW Biologics Inc. MIRAMAR, Fla., April 13, 2023 (GLOBE...
HCW Logo_Full_Color_600x_JPEG (2).jpg
HCW Biologics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Business Highlights
March 28, 2023 16:25 ET | HCW Biologics, Inc
MIRAMAR, Fla., March 28, 2023 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and...
HCW Logo_Full_Color_600x_JPEG (2).jpg
Masonic Cancer Center, University of Minnesota to Present Data in Poster Presentation From the Phase 1 Clinical Trial to Evaluate HCW9218 in Solid Tumors At the SITC 37th Annual Meeting
November 08, 2022 07:00 ET | HCW Biologics, Inc
Presentation includes data on safety and dosage escalationand immune system reaction to HCW9218 No incidence of mucosal bleeding resulting from the HCW9218 TGF-β trap HCW9218 is one of the lead...
HCW Logo_Full_Color_600x_JPEG (2).jpg
HCW Biologics Reports Third Quarter 2022 Financial Results And Recent Business Highlights
November 07, 2022 16:45 ET | HCW Biologics, Inc
MIRAMAR, Fla., Nov. 07, 2022 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and...